Accession Number: | 0001209191-14-054896 |
Date: | 2014-08-26 |
Issuer: | AVANIR PHARMACEUTICALS, INC. (AVNR) |
Original Submission Date: |
OCAMPO CHRISTINE
20 ENTERPRISE, SUITE 200
ALISO VIEJO, CA 92656
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2014-08-26 | S | 2,110 | d | $6.10 | 79,871 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sales reported on this from 4 were effected pursuant to a trading plan adopted pursuant to rule 10b5-1 under the securities exchange act of 1934, as amended. |
f2 | includes previously reported shares of common stock underlying restricted stock units granted to the reporting person, which are subject to certain vesting conditions. |